Loading…
The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma
In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging dia...
Saved in:
Published in: | Korean journal of radiology 2021, 22(1), , pp.23-40 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243 |
---|---|
cites | cdi_FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243 |
container_end_page | 40 |
container_issue | 1 |
container_start_page | 23 |
container_title | Korean journal of radiology |
container_volume | 22 |
creator | Rhee, Hyungjin Park, Mi Suk |
description | In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging diagnosis and resectability evaluation are the most important factors influencing treatment decisions, where computed tomography (CT) is the preferred modality. EUS, MRI, and positron emission tomography play a complementary role to CT. Treatment response evaluation is of increasing clinical importance, especially in patients undergoing neoadjuvant therapy. This review aimed to comprehensively review the role of imaging in relation to the current treatment strategy for pancreatic cancer, including surveillance, diagnosis, evaluation of resectability and treatment response, and prediction of prognosis. |
doi_str_mv | 10.3348/kjr.2019.0862 |
format | article |
fullrecord | <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9626420</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2441286040</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243</originalsourceid><addsrcrecordid>eNpdkUFv1DAQhS0EokvhyBVZ4gKHLOOxk9gXpNWKwkqVgLKcLcfrbL2b2K2TIPHv63RLBZxmpPn8_GYeIa8ZLDkX8sPxkJYITC1BVviELBCgLCTn8JQsGKIqKoXqjLwYhgMAKpDiOTnjuWGilAvyfXvt6FXsHI0t3fRm78Oe-kDXU0oujHSbnBn7ufsxJjO6vXcDbWOi30yw88xbutq5EK1J1ofYm5fkWWu6wb16qOfk58Wn7fpLcfn182a9uiysEGossFLVLlu2qq5r4KwxUINpFZRSqGZnlWtBAhdoGmROyNYwaJSUpZFcIQp-Tt6fdENq9dF6HY2_r_uoj0mvrrYbrSqsBEJmP57Ym6np3c7mfZLp9E3yvUm_71_-Own-Ouv80tkbcsmywLsHgRRvJzeMuveDdV1ngovToFEIhrICMf_19j_0EKcU8ik01iihLLmoMlWcKJviMCTXPpphoOdgdQ5Wz8HqOdjMv_l7g0f6T5L8DlRKnP8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2728055346</pqid></control><display><type>article</type><title>The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Rhee, Hyungjin ; Park, Mi Suk</creator><creatorcontrib>Rhee, Hyungjin ; Park, Mi Suk</creatorcontrib><description>In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging diagnosis and resectability evaluation are the most important factors influencing treatment decisions, where computed tomography (CT) is the preferred modality. EUS, MRI, and positron emission tomography play a complementary role to CT. Treatment response evaluation is of increasing clinical importance, especially in patients undergoing neoadjuvant therapy. This review aimed to comprehensively review the role of imaging in relation to the current treatment strategy for pancreatic cancer, including surveillance, diagnosis, evaluation of resectability and treatment response, and prediction of prognosis.</description><identifier>ISSN: 1229-6929</identifier><identifier>EISSN: 2005-8330</identifier><identifier>DOI: 10.3348/kjr.2019.0862</identifier><identifier>PMID: 32901458</identifier><language>eng</language><publisher>Korea (South): The Korean Society of Radiology</publisher><subject>Adenocarcinoma - diagnostic imaging ; Adenocarcinoma - pathology ; Adenocarcinoma - therapy ; Asymptomatic ; Bile ducts ; Cancer therapies ; Chemotherapy ; Endoscopy ; Gastrointestinal Imaging ; Humans ; Lymphatic system ; Magnetic Resonance Imaging ; Metastasis ; Neoadjuvant Therapy ; Neoplasm Staging ; Pancreatic cancer ; Pancreatic Neoplasms - diagnostic imaging ; Pancreatic Neoplasms - pathology ; Pancreatic Neoplasms - therapy ; Positron-Emission Tomography ; Prognosis ; Radiation therapy ; Surveillance ; Tomography ; Tomography, X-Ray Computed ; Tumors ; Ultrasonic imaging ; Ultrasonography ; 방사선과학</subject><ispartof>Korean Journal of Radiology, 2021, 22(1), , pp.23-40</ispartof><rights>Copyright © 2021 The Korean Society of Radiology.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2021 The Korean Society of Radiology 2021 The Korean Society of Radiology</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243</citedby><cites>FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243</cites><orcidid>0000-0001-7759-4458 ; 0000-0001-5817-2444</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2728055346/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2728055346?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32901458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002659363$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Rhee, Hyungjin</creatorcontrib><creatorcontrib>Park, Mi Suk</creatorcontrib><title>The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma</title><title>Korean journal of radiology</title><addtitle>Korean J Radiol</addtitle><description>In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging diagnosis and resectability evaluation are the most important factors influencing treatment decisions, where computed tomography (CT) is the preferred modality. EUS, MRI, and positron emission tomography play a complementary role to CT. Treatment response evaluation is of increasing clinical importance, especially in patients undergoing neoadjuvant therapy. This review aimed to comprehensively review the role of imaging in relation to the current treatment strategy for pancreatic cancer, including surveillance, diagnosis, evaluation of resectability and treatment response, and prediction of prognosis.</description><subject>Adenocarcinoma - diagnostic imaging</subject><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma - therapy</subject><subject>Asymptomatic</subject><subject>Bile ducts</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>Endoscopy</subject><subject>Gastrointestinal Imaging</subject><subject>Humans</subject><subject>Lymphatic system</subject><subject>Magnetic Resonance Imaging</subject><subject>Metastasis</subject><subject>Neoadjuvant Therapy</subject><subject>Neoplasm Staging</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - diagnostic imaging</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pancreatic Neoplasms - therapy</subject><subject>Positron-Emission Tomography</subject><subject>Prognosis</subject><subject>Radiation therapy</subject><subject>Surveillance</subject><subject>Tomography</subject><subject>Tomography, X-Ray Computed</subject><subject>Tumors</subject><subject>Ultrasonic imaging</subject><subject>Ultrasonography</subject><subject>방사선과학</subject><issn>1229-6929</issn><issn>2005-8330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkUFv1DAQhS0EokvhyBVZ4gKHLOOxk9gXpNWKwkqVgLKcLcfrbL2b2K2TIPHv63RLBZxmpPn8_GYeIa8ZLDkX8sPxkJYITC1BVviELBCgLCTn8JQsGKIqKoXqjLwYhgMAKpDiOTnjuWGilAvyfXvt6FXsHI0t3fRm78Oe-kDXU0oujHSbnBn7ufsxJjO6vXcDbWOi30yw88xbutq5EK1J1ofYm5fkWWu6wb16qOfk58Wn7fpLcfn182a9uiysEGossFLVLlu2qq5r4KwxUINpFZRSqGZnlWtBAhdoGmROyNYwaJSUpZFcIQp-Tt6fdENq9dF6HY2_r_uoj0mvrrYbrSqsBEJmP57Ym6np3c7mfZLp9E3yvUm_71_-Own-Ouv80tkbcsmywLsHgRRvJzeMuveDdV1ngovToFEIhrICMf_19j_0EKcU8ik01iihLLmoMlWcKJviMCTXPpphoOdgdQ5Wz8HqOdjMv_l7g0f6T5L8DlRKnP8</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Rhee, Hyungjin</creator><creator>Park, Mi Suk</creator><general>The Korean Society of Radiology</general><general>대한영상의학회</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope><orcidid>https://orcid.org/0000-0001-7759-4458</orcidid><orcidid>https://orcid.org/0000-0001-5817-2444</orcidid></search><sort><creationdate>20210101</creationdate><title>The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma</title><author>Rhee, Hyungjin ; Park, Mi Suk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenocarcinoma - diagnostic imaging</topic><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma - therapy</topic><topic>Asymptomatic</topic><topic>Bile ducts</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>Endoscopy</topic><topic>Gastrointestinal Imaging</topic><topic>Humans</topic><topic>Lymphatic system</topic><topic>Magnetic Resonance Imaging</topic><topic>Metastasis</topic><topic>Neoadjuvant Therapy</topic><topic>Neoplasm Staging</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - diagnostic imaging</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pancreatic Neoplasms - therapy</topic><topic>Positron-Emission Tomography</topic><topic>Prognosis</topic><topic>Radiation therapy</topic><topic>Surveillance</topic><topic>Tomography</topic><topic>Tomography, X-Ray Computed</topic><topic>Tumors</topic><topic>Ultrasonic imaging</topic><topic>Ultrasonography</topic><topic>방사선과학</topic><toplevel>online_resources</toplevel><creatorcontrib>Rhee, Hyungjin</creatorcontrib><creatorcontrib>Park, Mi Suk</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Korean journal of radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rhee, Hyungjin</au><au>Park, Mi Suk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma</atitle><jtitle>Korean journal of radiology</jtitle><addtitle>Korean J Radiol</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>22</volume><issue>1</issue><spage>23</spage><epage>40</epage><pages>23-40</pages><issn>1229-6929</issn><eissn>2005-8330</eissn><abstract>In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging diagnosis and resectability evaluation are the most important factors influencing treatment decisions, where computed tomography (CT) is the preferred modality. EUS, MRI, and positron emission tomography play a complementary role to CT. Treatment response evaluation is of increasing clinical importance, especially in patients undergoing neoadjuvant therapy. This review aimed to comprehensively review the role of imaging in relation to the current treatment strategy for pancreatic cancer, including surveillance, diagnosis, evaluation of resectability and treatment response, and prediction of prognosis.</abstract><cop>Korea (South)</cop><pub>The Korean Society of Radiology</pub><pmid>32901458</pmid><doi>10.3348/kjr.2019.0862</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0001-7759-4458</orcidid><orcidid>https://orcid.org/0000-0001-5817-2444</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1229-6929 |
ispartof | Korean Journal of Radiology, 2021, 22(1), , pp.23-40 |
issn | 1229-6929 2005-8330 |
language | eng |
recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_9626420 |
source | Publicly Available Content Database; PubMed Central |
subjects | Adenocarcinoma - diagnostic imaging Adenocarcinoma - pathology Adenocarcinoma - therapy Asymptomatic Bile ducts Cancer therapies Chemotherapy Endoscopy Gastrointestinal Imaging Humans Lymphatic system Magnetic Resonance Imaging Metastasis Neoadjuvant Therapy Neoplasm Staging Pancreatic cancer Pancreatic Neoplasms - diagnostic imaging Pancreatic Neoplasms - pathology Pancreatic Neoplasms - therapy Positron-Emission Tomography Prognosis Radiation therapy Surveillance Tomography Tomography, X-Ray Computed Tumors Ultrasonic imaging Ultrasonography 방사선과학 |
title | The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T22%3A25%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Imaging%20in%20Current%20Treatment%20Strategies%20for%20Pancreatic%20Adenocarcinoma&rft.jtitle=Korean%20journal%20of%20radiology&rft.au=Rhee,%20Hyungjin&rft.date=2021-01-01&rft.volume=22&rft.issue=1&rft.spage=23&rft.epage=40&rft.pages=23-40&rft.issn=1229-6929&rft.eissn=2005-8330&rft_id=info:doi/10.3348/kjr.2019.0862&rft_dat=%3Cproquest_nrf_k%3E2441286040%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2728055346&rft_id=info:pmid/32901458&rfr_iscdi=true |